Nuveen Municipal Value Fund (NUV) Competitors

Nuveen Municipal Value Fund (NYSE:NUV) and iShares Biotechnology ETF (NASDAQ:IBB) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Does the MarketBeat Community favor NUV or IBB?

iShares Biotechnology ETF received 28 more outperform votes than Nuveen Municipal Value Fund when rated by MarketBeat users. Likewise, 67.09% of users gave iShares Biotechnology ETF an outperform vote while only 65.83% of users gave Nuveen Municipal Value Fund an outperform vote.

Company	Underperform	Outperform
Nuveen Municipal Value Fund	Outperform Votes 131 65.83%	Underperform Votes 68 34.17%
iShares Biotechnology ETF	Outperform Votes 159 67.09%	Underperform Votes 78 32.91%

Which has higher earnings and valuation, NUV or IBB?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuveen Municipal Value Fund	N/A	N/A	N/A	N/A	N/A
iShares Biotechnology ETF	N/A	N/A	N/A	N/A	N/A

Do analysts recommend NUV or IBB?

Given iShares Biotechnology ETF's higher possible upside, analysts plainly believe iShares Biotechnology ETF is more favorable than Nuveen Municipal Value Fund.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nuveen Municipal Value Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
iShares Biotechnology ETF	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.56

Does the media favor NUV or IBB?

In the previous week, Nuveen Municipal Value Fund and Nuveen Municipal Value Fund both had 3 articles in the media. Nuveen Municipal Value Fund's average media sentiment score of 1.65 beat iShares Biotechnology ETF's score of 0.47 indicating that Nuveen Municipal Value Fund is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nuveen Municipal Value Fund	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
iShares Biotechnology ETF	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals believe in NUV or IBB?

22.5% of Nuveen Municipal Value Fund shares are owned by institutional investors. Comparatively, 62.5% of iShares Biotechnology ETF shares are owned by institutional investors. 1.0% of Nuveen Municipal Value Fund shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Is NUV or IBB more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Nuveen Municipal Value Fund	N/A	N/A	N/A
iShares Biotechnology ETF	N/A	N/A	N/A

Which has more volatility and risk, NUV or IBB?

Nuveen Municipal Value Fund has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500. Comparatively, iShares Biotechnology ETF has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.

Is NUV or IBB a better dividend stock?

Nuveen Municipal Value Fund pays an annual dividend of $0.34 per share and has a dividend yield of 4.0%. iShares Biotechnology ETF pays an annual dividend of $0.40 per share and has a dividend yield of 0.3%.

Summary

iShares Biotechnology ETF beats Nuveen Municipal Value Fund on 6 of the 9 factors compared between the two stocks.